| Filed On | Filing |
|---|---|
| 06 May 2026 | Form 3: Huber Martin H. Jr., Director |
| 14 Aug 2024 |
Form 3: Bios 2024 Co-Invest, Lp, Director
Holds 125,000 shares of Common Stock |
| 14 Aug 2024 |
Form 3: Ronneberg Amy L, Director
No securities owned |
| 14 Aug 2024 |
Form 3: Sawhney Roger, Director
No securities owned |
| 12 Aug 2024 |
Form 3: Zabrowski Dan, Director
Holds 76,348 shares of Common Stock |
| 12 Aug 2024 |
Form 3: Schmitt Daniel M, Director
Holds 22,223 shares of Common Stock |
| 12 Aug 2024 |
Form 3: Mazar Andrew Paul, Chief Operating Officer
Holds 127,250 shares of Common Stock |
| 12 Aug 2024 |
Form 3: Lytle Paul J, Chief Financial Officer
No securities owned |
| 12 Aug 2024 |
Form 3: Keyes Jason A, Director
No securities owned |
| 12 Aug 2024 |
Form 3: Thomson Todd S, Director and 4 others
Holds 47,318 shares of Common Stock |
| 12 Aug 2024 |
Form 3: Bios Clinical Opportunity Fund, Lp, 10% owner and 2 others
Holds 84,917 shares of Common Stock |
| 12 Aug 2024 |
Form 3: Fletcher Aaron G.l., Director and 9 others
Holds 84,917 shares of Common Stock |
| 12 Aug 2024 |
Form 3: Kreis Leslie W., 10% owner and 9 others
Holds 84,917 shares of Common Stock |
Loading...
